Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Pulmonary hypertension
Pulmonary arterial hypertension
Pulmonary arterial hypertension (PAH) is a group of diseases characterized by mean pulmonary artery pressure >20 mmHg and elevated pulmonary arterial resistance leading to right heart failure. PAH is progressive and potentially fatal. PAH may be idiopathic and/ or familial, have overt features of venous/capillary involvement (pulmonary veno-occlusive disease, PVOD/pulmonary capillary hemangiomatosis, PCH), induced by drug or toxin (drug-or toxin-induced PAH), or associated with other diseases like congenital heart disease, connective tissue disease, HIV, schistosomiasis, portal hypertension (PAH associated with other disease).
-
Heritable pulmonary arterial hypertension 10 trials · 11 incl. sub-types Sub-types →
-
Eisenmenger syndrome 5 trials